An Open-Label, Long-Term Treatment Study to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane With Subjective Tinnitus

Trial Profile

An Open-Label, Long-Term Treatment Study to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane With Subjective Tinnitus

Discontinued
Phase of Trial: Phase III

Latest Information Update: 26 Aug 2014

At a glance

  • Drugs Neramexane (Primary)
  • Indications Tinnitus
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms OLLTT
  • Most Recent Events

    • 20 Mar 2012 Planned patients number (840) added as reported by European Clinical Trials Database.
    • 16 Mar 2012 Planned end date changed from 1 Jul 2012 to 1 Dec 2011 as reported by ClinicalTrials.gov.
    • 16 Mar 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top